Digital health creative must pass a review process most consumer brands never encounter, and that process typically wins by default, resulting in stock-photo sameness and hedge-everything copy that converts no one. We create a production system that clears review while still making people stop scrolling.
Your review process is designed for zero risk, quietly resulting in zero impact
Every claim, image, and even color choice in health creative can trigger a legal or medical-review flag, so the path of least resistance is to strip out anything specific, emotional, or memorable. The result is creative that clears review cleanly and performs poorly, because the same caution that avoids risk also avoids the specificity that makes an ad work. Teams rarely notice this trade-off happening because each individual edit looks reasonable in isolation.
You are creating only a fraction of the volume your performance channels actually require
Paid social and search require constant creative refresh to avoid fatigue, but a health company's review cycle can take days or weeks per asset, so teams end up running the same three ads for months. Creative fatigue quietly erodes CPMs and CTR while the team assumes the channel itself is underperforming. The bottleneck is production throughput, not channel strategy, and most digital health marketing teams have never built a pipeline designed to clear review fast enough to keep pace.
Every asset feels pulled from a stock library because producing custom creative seems too slow to be worthwhile
Given the review overhead, teams default to stock photography and template layouts because commissioning original photography or illustration feels like adding more review cycles on top of an already slow process. That decision compounds – every competitor makes the same call, so the entire category looks identical, and differentiation becomes impossible on the surface where a user actually decides whether to trust you.
Your creative and clinical teams speak different languages, with nobody bridging the gap between them
Marketing wants an emotionally resonant hook, medical and legal want a defensible, substantiated claim, and without someone who can build both into the same asset, creative gets bounced back and forth in a slow negotiation that exhausts everyone and ships watered-down work. Most teams do not have a single owner who can write copy that is simultaneously persuasive and clinically accurate on the first draft.
We begin by auditing your existing review process to identify where creative loses its impact – which claim types are automatically rejected, which visual decisions raise concerns, and where your team's caution reflects regulatory necessity rather than habit. That distinction defines what can truly be produced, yet most teams have never separated the two.
We then create a creative system rather than a collection of one-off assets: a library of pre-cleared claim structures, visual directions, and copy patterns already validated by your legal and medical reviewers. This allows new creative to be assembled using approved building blocks instead of restarting the review negotiation from scratch each time.
Production follows a cadence designed around your review timeline rather than working against it. If legal review requires five business days, we batch and submit creative on a schedule that keeps a steady supply moving through the pipeline, ensuring your paid channels never run out while waiting for approval – the single largest driver of creative fatigue in this category.
Wherever the budget permits, we replace stock photography with a combination of original photography, illustration, and motion created specifically for your brand and audience, because the visual uniformity of digital health creative is one of the simplest gaps to exploit. Once the review-ready system exists, custom creative does not have to mean slower production.
Each asset is crafted to be both persuasive and substantiated, rooted in claims your legal and medical teams can genuinely support. As a result, the back-and-forth that usually delays production happens once at the system level rather than with every individual asset.
Unlike a standard creative agency, we design the production pipeline around your particular review constraints from day one, rather than developing creative in isolation and learning during review that half of the work must be redone.
Digital health creative does not struggle because of the review process itself—it struggles because no one distinguishes regulatory necessity from habit, and habit is what quietly reduces every ad to a stock image and a hedge.
We operate digital health creative production as a 90-day sprint. During the first 30 days, we audit your review process and existing creative library to distinguish genuine constraints from habitual ones, then use that audit to develop a pre-cleared claim and visual library. From days 30 through 60, we establish the production pipeline around your legal and medical review turnaround and deliver the first wave of custom creative to replace stock-heavy assets. Days 60 through 90 set the ongoing cadence and transfer a system that your internal team or agency of record can continue operating.
Where a general creative agency sees compliance review as an outside obstacle to navigate, we incorporate review timing into the production plan from the outset. In digital health, the review cycle is the true production constraint, not an end-stage formality. Success is measured by whether creative passes review on the first attempt and whether channels receive enough fresh supply to prevent fatigue – not only by how the work appears in a deck.
The first 30 days focus on auditing your review process and current creative output, pinpointing where impact is lost and developing a pre-cleared library of claims and visual approaches that your legal and medical reviewers approve in advance.
During days 30 through 60, we establish production at a cadence aligned with your review turnaround and ship the first round of custom creative developed from the pre-cleared library. We need early access to your review team and a clear picture of your legal risk tolerance, as both determine what we can create.
From days 60 through 90, we transition into steady-state production, with volume calibrated to keep your paid channels stocked with fresh creative and prevent the fatigue caused by running the same small group of assets for too long. Initial builds typically run three to six months, with production support available afterward on a retainer basis if your team needs continued volume.
Our cadence features a weekly production review and direct access to your legal and medical reviewers, keeping approval turnaround predictable rather than allowing it to become the usual bottleneck.
If your digital health company needs creative production leadership, we should talk.
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Pricing depends on production volume, the combination of photography, illustration, and motion, and whether the pre-cleared claim library must be created from scratch or adapted from existing approved assets. Onboarding costs less for a company with an established legal review relationship than for one requiring us to build the claim library from zero.
The pre-cleared claim library and initial production cadence are generally established within 60 days. Paid-channel performance impact appears once fresh creative begins flowing consistently, typically during the first month of steady production, because the primary lever is resolving fatigue caused by an insufficient supply of new creative.
We partner directly with your legal and medical reviewers to develop the pre-cleared library at the outset, then submit new creative on a schedule aligned with their actual turnaround so they never become an unexpected bottleneck. For this approach to work, we require a designated reviewer with reliable availability.
A traditional creative agency views compliance review as an obstacle to navigate once the work is complete. We incorporate the review constraint into the production plan from day one because, in digital health, the review cycle defines what can realistically ship – not merely how the work appears.
We monitor review pass rate, the time between brief and live asset, and downstream performance measures such as CTR and CPM stability as fresh creative takes the place of fatigued assets. The central measure is whether your paid channels consistently receive enough new, cleared creative to prevent the performance decline caused by running identical ads for too long.
This service suits companies with active paid media programs experiencing creative fatigue because production cannot match the pace of legal or medical review, generally in the 5M to 100M ARR range with an established but slow review process. If you do not have a review process yet, we can help create one, although the engagement scope will differ. Begin with a strategy call and a review of your current creative and approval timeline.
Tuesday, September 22, 2026
Frank Growth – Episode 238 – The Best Kept Secret Sport with Ozge Erturk
Tuesday, September 15, 2026
Frank Growth – Episode 237 – Stop Buying Users Who Leave with Michelle Matthews
Tuesday, September 8, 2026
Frank Growth – Episode 236 – Turn Marketers Into AI Strategists with Elyssa Steiner
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Ready to unlock your growth?
Book Free Call